IMCR
Immunocore Holdings plc
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Sell
-22/100
Last price
29.55
▼ 0.04 (0.14%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
29.59
Day high
30.28
Day low
29.40
Volume
662.60K
Market cap
$1.52B
P/E (TTM)
—
52W range
27.56 – 40.72
Trailing performance
Returnvs SPY
1W
-4.21%
-6.2%
1M
-18.21%
-19.4%
3M
-12.52%
-17.0%
6M
-7.54%
-25.7%
YTD
-14.87%
-29.1%
1Y
-13.62%
-30.0%
3Y
-43.06%
-125.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
11 more panels on IMCR open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
33.99K
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Feb 18, 26 | JALLAL BAHIJA Chief Executive Officer |
SELL | 11.47K | $371.18K | Direct |
| Feb 18, 26 | GOLL JOHN R Officer |
SELL | 698 | $22.58K | Direct |
| Feb 18, 26 | BERMAN DAVID M Officer |
SELL | 5.96K | $192.97K | Direct |
| Feb 18, 26 | ST LEGER TINA AMBER Officer |
SELL | 1.00K | $32.35K | Direct |
| Feb 17, 26 | JALLAL BAHIJA Chief Executive Officer |
— | 23.82K | — | Direct |
| Feb 17, 26 | GOLL JOHN R Officer |
— | 1.35K | — | Direct |
| Feb 17, 26 | BERMAN DAVID M Officer |
— | 11.82K | — | Direct |
| Feb 17, 26 | ST LEGER TINA AMBER Officer |
— | 2.12K | — | Direct |
| Dec 4, 25 | BERMAN DAVID M Officer |
CONVERSION | 31.34K | $1.26M | Direct |
| Nov 28, 25 | BERMAN DAVID M Officer |
CONVERSION | 74.92K | $1.31M | Direct |
| Nov 28, 25 | BERMAN DAVID M Officer |
SELL | 74.92K | $3.01M | Direct |
| Nov 25, 25 | BERMAN DAVID M Officer |
CONVERSION | 18.12K | $316.38K | Direct |
| Nov 25, 25 | BERMAN DAVID M Officer |
SELL | 18.12K | $725.34K | Direct |
| Sep 12, 25 | BERMAN DAVID M Officer |
CONVERSION | 22.53K | $794.03K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BAKER BROS ADVISORS L.P. |
Director | — | Purchase |
BERMAN DAVID M |
Officer | 5.86K | Sale |
GOLL JOHN R |
Officer | 653 | Sale |
JALLAL BAHIJA |
Chief Executive Officer | 12.34K | Sale |
ST LEGER TINA AMBER |
Officer | 1.12K | Sale |
Fundamentals
Market cap$1.52B
Enterprise value$1.08B
Revenue (TTM)$430.78M
Gross profit$141.59M
EBITDA$756.00K
Net income$-18.07M
EPS (TTM)$-0.36
Free cash flow$35.59M
Total cash$880.21M
Total debt$434.96M
Book value / share$8.16
Shares outstanding51.50M
Float45.83M
Short % of float16.76%
Dividend yield0.00%
Beta (5Y)0.82
Valuation & profitability ratios
Trailing P/E—
Forward P/E-39.17
PEG ratio—
Price / sales—
Price / book3.62
EV / revenue2.50
EV / EBITDA1,423.98
Gross margin32.87%
Operating margin-2.58%
Profit margin-4.20%
Return on equity-4.47%
Return on assets-0.16%
Debt / equity103.61
Current ratio4.47
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $400.02M | $310.20M | $249.43M | $174.36M | +29.0% |
| Operating revenue | $400.02M | $310.20M | $249.43M | $174.36M | +29.0% |
| Cost of revenue | $5.09M | $2.73M | $1.04M | $1.09M | +86.3% |
| Gross profit | $394.93M | $307.47M | $248.39M | $173.27M | +28.4% |
| Research & development | $274.87M | $222.15M | $163.54M | $101.92M | +23.7% |
| Selling, general & admin | $165.41M | $155.78M | $144.50M | $123.06M | +6.2% |
| Total operating expense | $440.28M | $377.93M | $308.04M | $224.98M | +16.5% |
| Operating income | -$45.35M | -$70.46M | -$59.65M | -$51.71M | +35.6% |
| Net interest income | $4.31M | $6.77M | $12.83M | -$1.65M | -36.4% |
| Pre-tax income | -$19.10M | -$52.94M | -$60.89M | -$40.88M | +63.9% |
| Tax provision | $16.41M | -$1.85M | -$5.60M | $11.66M | +987.2% |
| Net income | -$35.51M | -$51.09M | -$55.29M | -$52.54M | +30.5% |
| Net income to common | -$35.51M | -$51.09M | -$55.29M | -$52.54M | +30.5% |
| Basic EPS | -0.71 | -1.02 | -1.13 | -1.09 | +30.4% |
| Diluted EPS | -0.71 | -1.02 | -1.13 | -1.09 | +30.4% |
| EBIT | -$6.93M | -$34.09M | -$55.74M | -$35.47M | +79.7% |
| EBITDA | -$3.67M | -$29.89M | -$51.65M | -$30.14M | +87.7% |
| Basic shares | 50.35M | 49.99M | 48.89M | 45.80M | +0.7% |
| Diluted shares | 50.35M | 49.99M | 48.89M | 45.80M | +0.7% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $467.71M | $455.73M | $442.63M | $402.47M | — | +2.6% |
| Cash & short-term investments | $864.15M | $820.38M | $442.63M | $402.47M | — | +5.3% |
| Accounts receivable | $73.98M | $63.01M | $52.09M | $33.58M | — | +17.4% |
| Inventory | $6.74M | $5.45M | $4.50M | $692.00K | — | +23.8% |
| Total current assets | $996.74M | $929.86M | $528.82M | $473.98M | — | +7.2% |
| Property, plant & equipment | $50.24M | $47.73M | $42.73M | $38.78M | — | +5.3% |
| Goodwill & intangibles | — | — | — | $410.00K | $0 | — |
| Total assets | $1.07B | $1.01B | $597.00M | $526.76M | — | +5.7% |
| Total current liabilities | $246.70M | $212.18M | $139.02M | $100.83M | — | +16.3% |
| Long-term debt | $393.13M | $391.01M | $48.01M | $47.81M | — | +0.5% |
| Total debt | $436.69M | $432.72M | $85.01M | $81.45M | — | +0.9% |
| Total liabilities | $686.24M | $648.79M | $228.16M | $187.86M | — | +5.8% |
| Retained earnings | -$831.27M | -$795.76M | -$744.67M | -$689.39M | — | -4.5% |
| Shareholder equity | $381.03M | $360.72M | $368.84M | $338.90M | — | +5.6% |
| Working capital | $750.04M | $717.68M | $389.80M | $373.14M | — | +4.5% |
| Net tangible assets | $381.03M | $360.72M | $368.84M | $338.90M | — | +5.6% |
| Shares issued | 50.69M | 50.06M | 49.73M | 48.09M | — | +1.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$35.51M | -$51.09M | -$55.29M | -$52.54M | — | +30.5% |
| Depreciation & amortisation | $3.27M | $4.20M | $4.09M | $5.33M | — | -22.3% |
| Stock-based compensation | $37.70M | $34.19M | $32.47M | $32.89M | — | +10.3% |
| Change in working capital | -$9.30M | $48.95M | $11.63M | -$24.16M | — | -119.0% |
| Operating cash flow | -$10.71M | $26.06M | $2.94M | -$49.21M | — | -141.1% |
| Capital expenditure | -$4.34M | -$5.17M | -$5.42M | -$2.20M | — | +16.1% |
| Investing cash flow | -$16.34M | -$355.13M | -$5.42M | -$2.20M | — | +95.4% |
| Dividends paid | — | — | — | $0 | $0 | — |
| Financing cash flow | $12.37M | $343.88M | $34.35M | $145.44M | — | -96.4% |
| Free cash flow | -$15.05M | $20.89M | -$2.48M | -$51.41M | — | -172.1% |
| End cash position | $467.71M | $455.73M | $442.63M | $402.47M | — | +2.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $115.93M | $106.68M | $104.48M | $103.69M | $97.96M | +8.7% |
| Operating revenue | $115.93M | $106.68M | $104.48M | $103.69M | $97.96M | +8.7% |
| Cost of revenue | $1.09M | $434.00K | $2.70M | $513.00K | $1.04M | +150.7% |
| Gross profit | $114.84M | $106.24M | $101.78M | $103.18M | $96.92M | +8.1% |
| Research & development | $73.94M | $61.11M | $78.82M | $70.57M | $69.01M | +21.0% |
| Selling, general & admin | $43.89M | $37.85M | $42.65M | $39.78M | $42.79M | +16.0% |
| Total operating expense | $117.83M | $98.96M | $121.47M | $110.35M | $111.80M | +19.1% |
| Operating income | -$3.00M | $7.28M | -$19.69M | -$7.17M | -$14.88M | -141.2% |
| Net interest income | $520.00K | $367.00K | $853.00K | $1.08M | $1.23M | +41.7% |
| Pre-tax income | -$514.00K | $13.27M | -$15.79M | $304.00K | -$9.69M | -103.9% |
| Tax provision | $294.00K | $301.00K | $14.27M | $481.00K | $606.00K | -2.3% |
| Net income | -$808.00K | $12.97M | -$30.06M | -$177.00K | -$10.30M | -106.2% |
| Net income to common | -$808.00K | $12.97M | -$30.06M | -$177.00K | -$10.30M | -106.2% |
| Basic EPS | -0.02 | 0.26 | -0.60 | 0.00 | -0.20 | -107.7% |
| Diluted EPS | -0.02 | 0.25 | -0.60 | 0.00 | -0.20 | -108.0% |
| EBIT | $2.00M | $16.32M | -$11.18M | $2.82M | -$7.18M | -87.7% |
| EBITDA | $3.03M | $17.27M | -$10.34M | $3.62M | -$6.40M | -82.5% |
| Basic shares | 50.97M | 50.75M | 50.47M | 50.40M | 50.29M | +0.4% |
| Diluted shares | 50.97M | 52.93M | 50.47M | 50.40M | 50.29M | -3.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $484.92M | $452.68M | $467.71M | $498.41M | $487.93M | +7.1% |
| Cash & short-term investments | $880.21M | $844.90M | $864.15M | $892.35M | $882.81M | +4.2% |
| Accounts receivable | $95.35M | $81.07M | $73.98M | $75.88M | $69.76M | +17.6% |
| Inventory | $7.79M | $8.25M | $6.74M | $5.66M | $5.46M | -5.6% |
| Total current assets | $1.05B | $1.00B | $996.74M | $1.02B | $1.00B | +4.7% |
| Property, plant & equipment | $49.88M | $49.67M | $50.24M | $48.83M | $48.98M | +0.4% |
| Total assets | $1.12B | $1.07B | $1.07B | $1.10B | $1.08B | +4.4% |
| Total current liabilities | $235.20M | $240.11M | $246.70M | $170.35M | $170.08M | -2.0% |
| Long-term debt | $394.21M | $393.66M | $393.13M | $392.59M | $392.06M | +0.1% |
| Total debt | $434.96M | $435.68M | $436.69M | $435.86M | $436.46M | -0.2% |
| Total liabilities | $699.62M | $678.42M | $686.24M | $705.94M | $693.91M | +3.1% |
| Retained earnings | -$819.11M | -$818.30M | -$831.27M | -$801.22M | -$801.04M | -0.1% |
| Shareholder equity | $419.80M | $393.67M | $381.03M | $396.56M | $388.48M | +6.6% |
| Working capital | $815.85M | $763.69M | $750.04M | $852.50M | $832.22M | +6.8% |
| Net tangible assets | $419.80M | $393.67M | $381.03M | $396.56M | $388.48M | +6.6% |
| Shares issued | 51.48M | 50.83M | 50.69M | 50.47M | 50.37M | +1.3% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$808.00K | $12.97M | -$30.06M | -$177.00K | -$10.30M | -106.2% |
| Depreciation & amortisation | $1.03M | $948.00K | $834.00K | $798.00K | $780.00K | +8.2% |
| Stock-based compensation | $9.40M | $6.30M | $8.34M | $9.84M | $10.03M | +49.2% |
| Change in working capital | $7.41M | -$29.89M | -$27.10M | -$1.32M | $26.74M | +124.8% |
| Operating cash flow | $15.93M | -$13.78M | -$32.66M | -$4.46M | $25.96M | +215.6% |
| Capital expenditure | -$786.00K | -$1.78M | -$2.88M | -$748.00K | -$414.00K | +55.9% |
| Investing cash flow | -$786.00K | $4.22M | -$880.00K | $5.25M | -$30.41M | -118.6% |
| Financing cash flow | $16.48M | $656.00K | $4.28M | $1.87M | $3.67M | +2,413.0% |
| Free cash flow | $15.14M | -$15.56M | -$35.53M | -$5.20M | $25.55M | +197.3% |
| End cash position | $484.92M | $452.68M | $467.71M | $498.41M | $487.93M | +7.1% |
Options analytics
Put / call volume
217.74
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
17.50
-40.8% from spot
ATM implied vol
3.1%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
23
Contracts, this expiry
Put volume
5.01K
Contracts, this expiry
Heaviest call OI
17.50
0 contracts
Heaviest put OI
20.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.02 | -0.02 | -195.6% |
| Mar 2026 | -0.26 | 0.25 | +196.5% |
| Dec 2025 | -0.20 | -0.60 | -196.0% |
| Sep 2025 | -0.24 | 0.00 | +100.0% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.12 | 12 | $113.35M | +9.3% |
| Next quarter | -0.18 | 12 | $116.53M | +11.5% |
| Current year | -0.04 | 11 | $452.25M | +13.1% |
| Next year | -0.75 | 12 | $488.96M | +8.1% |
Analyst targets & ownership
Mean target$62.73
High target$100.00
Low target$34.00
Implied upside112.28%
Analyst count11
ConsensusSTRONG BUY
Strong buy / Buy1 / 2
Hold0
Sell / Strong sell0 / 0
Held by insiders0.07%
Held by institutions103.17%
Institutions holding177
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
30.47
-3.03% from price
SMA 20
31.50
-6.20% from price
SMA 50
33.77
-12.51% from price
SMA 100
32.26
-8.40% from price
SMA 200
32.12
-8.00% from price
EMA 12
30.73
-3.85% from price
EMA 26
32.01
-7.69% from price
EMA 50
32.72
-9.68% from price
RSI (14)
27.6
Oversold
MACD (12,26,9)
-1.28
Hist -0.16
ATR (14)
1.17
3.95% of price
Realised vol 30D
24.9%
Annualised
Bollinger upper
34.05
20, 2σ
Bollinger lower
28.96
20, 2σ
50 / 200 cross
Golden
33.77 vs 32.12
Trend bias
Below 200
-8.00%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.63
Less volatile than market
Correlation to SPY
0.22
Largely independent
Realised vol 30D
24.9%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-30.9%
Peak to trough
Max drawdown 5Y
-67.4%
Peak to trough
ATR 14
1.17
3.95% of price
Beta (reported)
0.82
5Y monthly, from filing
Short interest
Shares short
7.77M
Prior 7.90M
Change vs prior
-1.6%
Shorts covering
% of float
16.76%
Elevated
% of shares out
15.09%
Against total outstanding
Days to cover
20.3
Crowded exit
Float
45.83M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 3, 26 | Mizuho | MAINTAINED | Neutral | Neutral |
| Apr 20, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Apr 14, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Mar 16, 26 | Jefferies | DOWNGRADE | Buy | Hold |
| Feb 26, 26 | Needham | MAINTAINED | Buy | Buy |
| Feb 4, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 10, 25 | Morgan Stanley | MAINTAINED | Equal-Weight | Equal-Weight |
| Oct 31, 25 | Wells Fargo | INITIATED | — | Overweight |
| Oct 22, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Jun 2, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 8, 25 | Oppenheimer | MAINTAINED | Outperform | Outperform |
| Apr 14, 25 | JP Morgan | MAINTAINED | Overweight | Overweight |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio—
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-14
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-05-27
Offering Registrations
S-8 · 2026-05-08
Corporate Changes & Voting Matters
8-K · 2026-05-06
Proxy Statements
DEF 14A · 2026-04-16
Corporate Changes & Voting Matters
8-K · 2026-02-25
Corporate Changes & Voting Matters
8-K · 2026-01-30
Headlines
Immunocore Hits Enrollment Target in Kimmtrak Label Expansion Study
Zacks · 22d ago
Immunocore announces achievement of target enrollment in registrational TEBE-AM trial with KIMMTRAK® (tebentafusp) in previously treated advanced melanoma
GlobeNewswire · 23d ago
Will Kimmtrak Continue to Aid IMCR's Growth Through the Rest of 2026?
Zacks · 43d ago
IMCR Q2 Revenues Climb 18.3% as Kimmtrak Demand Helps Offset EPS Miss
Zacks · 58d ago
How Strong H1 Profits and Kimtrak Survival Data At Immunocore (IMCR) Have Changed Its Investment Story
Simply Wall St. · 61d ago
Immunocore Q2 Earnings Call Highlights
MarketBeat · 62d ago
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Kimtrak Growth and Pipeline ...
GuruFocus.com · 62d ago
Immunocore Holdings PLC (IMCR) (Q2 2026) Earnings Call Highlights: Strong Kimtrak Growth and ...
GuruFocus.com · 62d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.